Abstract
Danon disease is a rare X-linked dominant lysosomal disease due to the primary deficiency of lysosome-associated membrane protein 2 (LAMP2) gene. Cardiomyopathy, skeletal myopathy and mental retardation are the typical triad of Danon disease. More than 60 LAMP2 mutations have been reported. The molecular mechanism is defects in LAMP2 protein (due to LAMP2 mutation) which causes insidious glycogen accumulation in cardiac muscle cells and resulting in cardiac hypertrophy and electrophysiological abnormalities. However, there are significant differences between the male and female Danon disease patients with regard to clinical features and cardiac manifestations. The clinical symptoms are variable, from asymptomatic to sudden cardiac death. Wolff–Parkinson–White syndrome is more common in male than female patients. Hypertrophic cardiomyopathy is predominant in male patients, whereas the similar prevalence of hypertrophic and dilated cardiomyopathy in female patients. Male patients are diagnosed usually at teenage, whereas the diagnosis and events occurred approximately 15 years later in female than male patients. Heart transplantation is the reliable treatment once the occurrence of heart failure and should be considered as early as possible due to its rapid progression.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Danon, M.J., Oh, S.J., DiMauro, S., Manaligod, J.R., Eastwood, A., Naidu, S. et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology 31, 51–57 (1981).
Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T. et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406, 906–910 (2000).
Cheng, Z., Cui, Q., Tian, Z., Xie, H., Chen, L., Fang, L. et al. Danon disease as a cause of concentric left ventricular hypertrophy in patients who underwent endomyocardial biopsy. Eur. Heart J. 33, 649–656 (2012).
Cottinet, S.L., Bergemer-Fouquet, A.M., Toutain, A., Sabourdy, F., Maakaroun-Vermesse, Z., Levade, T. et al. Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation. J. Inherit. Metab. Dis. 34, 515–522 (2011).
Boucek, D., Jirikowic, J., Taylor, M. Natural history of Danon disease. Genet. Med. 13, 563–568 (2011).
Kim, H., Cho, A., Lim, B.C., Kim, M.J., Kim, K.J., Nishino, I. et al. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease. Muscle Nerve 41, 879–882 (2010).
Yang, Z., Funke, B.H., Cripe, L.H., Vick, G.W., Mancini-Dinardo, D., Peña, L.S. et al. LAMP2 microdeletions in patients with Danon disease. Circ.Cardiovasc. Genet. 3, 129–137 (2010).
Toib, A., Grange, D.K., Kozel, B.A., Ewald, G.A., White, F.V., Canter, C.E. Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women. J. Am. Coll. Cardiol. 55, 408–410 (2010).
Sabourdy, F., Michelakakis, H., Anastasakis, A., Garcia, V., Mavridou, I., Nieto, M. et al. Danon disease: further clinical and molecular heterogeneity. Muscle Nerve 39, 837–844 (2009).
Regelsberger, G., Höftberger, R., Pickl, W.F., Zlabinger, G.J., Körmöczi, U., Salzer-Muhar, U. et al. Danon disease: case report and detection of new mutation. J. Inherit. Metab. Dis. doi:10.1007/s10545-009-1097-9. (2009).
Dougu, N., Joho, S., Shan, L., Shida, T., Matsuki, A., Uese, K. et al. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Circ. J. 73, 376–380 (2009).
Sugie, K., Yamamoto, A., Murayama, K., Oh, S.J., Takahashi, M., Mora, M. et al. Clinicopathological features of genetically confirmed Danon disease. Neurology 58, 1773–1778 (2002).
Mattei, M.G., Matterson, J., Chen, J.W., Williams, M.A., Fukuda, M. Two human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2, are encoded by genes localized to chromosome 13q34 and chromosome Xq24-25, respectively. J. Biol. Chem. 265, 7548–7551 (1990).
Maron, B.J., Roberts, W.C., Arad, M., Haas, T.S., Spirito, P., Wright, G.B. et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA 301, 1253–1259 (2009).
Arad, M., Maron, B.J., Gorham, J.M., Johnson, W.H., Saul, J.P., Perez-Atayde, A.R. et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352, 362–372 (2005).
Miani, D., Taylor, M., Mestroni, L., D'Aurizio, F., Finato, N., Fanin, M. et al. Sudden death associated with danon disease in women. Am. J. Cardiol. 109, 406–411 (2012).
Di Blasi, C., Jarre, L., Blasevich, F., Dassi, P., Mora, M. Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression. Neuromuscul. Disord. 18, 962–966 (2008).
Iascone, M., Iacovoni, A., Marchetti, D., Ferrazzi, P. Gene symbol: LAMP2. Disease: Danon disease. Hum. Genet. 123, 537 (2008).
van der Kooi, A.J., van Langen, I.M., Aronica, E., van Doorn, P.A., Wokke, J.H., Brusse, E. et al. Extension of the clinical spectrum of Danon disease. Neurology 70, 1358–1359 (2008).
Bui, Y.K., Renella, P., Martinez-Agosto, J.A., Verity, A., Madikians, A., Alejos, J.C. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation. Pediatr. Transplant 12, 246–250 (2008).
Nadeau, A., Therrien, C., Karpati, G., Sinnreich, M. Danon disease due to a novel splice mutation in the LAMP2 gene. Muscle Nerve 37, 338–342 (2008).
Tuñón, T., Guerrero, D., Urchaga, A., Nishino, I., Ayuso, T., Matsuda, Y. et al. Danon disease: a novel Lamp-2 gene mutation in a family with four affected members. Neuromuscul. Disord. 18, 167–174 (2008).
Taylor, M.R., Ku, L., Slavov, D., Cavanaugh, J., Boucek, M., Zhu, X. et al. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J. Hum. Genet. 52, 830–835 (2007).
Fanin, M., Nascimbeni, A.C., Fulizio, L., Spinazzi, M., Melacini, P., Angelini, C. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am. J. Pathol. 168, 1309–1320 (2006).
Echaniz-Laguna, A., Mohr, M., Epailly, E., Nishino, I., Charron, P., Richard, P. et al. Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Muscle Nerve 33, 393–397 (2006).
Yang, Z., McMahon, C.J., Smith, L.R., Bersola, J., Adesina, A.M., Breinholt, J.P. et al. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 112, 1612–1617 (2005).
Balmer, C., Ballhausen, D., Bosshard, N.U., Steinmann, B., Boltshauser, E., Bauersfeld, U. et al. Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene. Eur. J. Pediatr. 164, 509–514 (2005).
Lobrinus, J.A., Schorderet, D.F., Payot, M., Jeanrenaud, X., Bottani, A., Superti-Furga, A. et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromuscul. Disord. 15, 293–298 (2005).
Musumeci, O., Rodolico, C., Nishino, I., Di Guardo, G., Migliorato, A., Aguennouz, M. et al. Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene. Neuromuscul. Disord. 15, 409–411 (2005).
Charron, P., Villard, E., Sébillon, P., Laforêt, P., Maisonobe, T., Duboscq-Bidot, L. et al. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey. Heart 90, 842–846 (2004).
Horváth, J., Ketelsen, U.P., Geibel-Zehender, A., Boehm, N., Olbrich, H., Korinthenberg, R. et al. Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease. Neuropediatrics 34, 270–273 (2003).
Lacoste-Collin, L., Garcia, V., Uro-Coste, E., Arné-Bes, M.C., Durand, D., Levade, T. et al. Danon's disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation. Neuromuscul. Disord. 12, 882–885 (2002).
Takahashi, M., Yamamoto, A., Takano, K., Sudo, A., Wada, T., Goto, Y. et al. Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease). Ann. Neurol. 52, 122–125 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, Z., Fang, Q. Danon disease: focusing on heart. J Hum Genet 57, 407–410 (2012). https://doi.org/10.1038/jhg.2012.72
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2012.72
Keywords
This article is cited by
-
Sex Differences in Cardiomyopathy
Current Cardiovascular Risk Reports (2022)
-
Danon disease: a case report and literature review
Diagnostic Pathology (2021)
-
Cardiac manifestations in children with inborn errors of metabolism
Indian Pediatrics (2017)
-
Nuclear Imaging for Assessment of Myocardial Perfusion, Metabolism, and Innervation in Hypertrophic Cardiomyopathy
Current Cardiovascular Imaging Reports (2016)
-
LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease
Acta Neuropathologica Communications (2015)
